Policy and Legislation
CBO gives projections to House committee amid Johnson's CR stop-gap measure to avoid a government shutdown.
HIMSS25
Executive editors from Healthcare Finance News, Healthcare IT News and MobiHealthNews weigh in on what they've heard about the upcoming government spending bill, interoperability goals under the new administration and notable happenings on the show floor.
Tom Leary, senior vice president and head of Government Relations at HIMSS, gives a rundown of healthcare priorities.
HIMSS President and CEO Hal Wolf addresses research cuts, the workforce shortage and digital health during a press conference.
The administration is decrying what it calls "hidden" prices and "opaque" pricing arrangements.
Letter to CEO Andrew Witty follows report of DOJ launching investigation into the company's billing methods.
The FTC alleges anticompetitive and unfair rebating practices that artificially inflate the list price of insulin.
Sponsors say a pathway is important because many cancers currently lack an effective screening option.
The FTC maintains that PBMs systematically prefer high list price insulin products with high rebates and fees over low list products.
HIMSS25
As health disparities continue there needs to be a new way to address DEI amid administrative changes, say HIMSS25 Health Equity Forum speakers Dr. Chris Gibbons, Greystone Group founder and CEO, and Ysabel Duron, founder and executive director of the Latino Cancer Institute.